Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

The Midas Touch

The Midas Touch

Using this idea – that business-model innovation is all about optimising risk-adjusted return on investment – opens up a new way of thinking about how the industry is evolving. ... to myopically focus on the big bet, big risk, big pay-off business

Latest news

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    Just a few weeks ago, for example, UK-based Sensyne Health made its debut on the AIM, raising £60m to advance a business model based on sifting through anonymised NHS data

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    This is understandable but flawed, for at least two reasons. Firstly, it assumes that such firms have a single business model to copy, when in fact they are coalitions of businesses ... This is another example, after divesting itself of its respiratory

  • AI company Sensyne raises £60m in IPO AI company Sensyne raises £60m in IPO

    business model that is based on sifting through NHS data to find clinical leads. ... Lord Drayson – who was one of the founders of PowderJect Pharma in 1993 and sold the company 10 years later for £540m - said that the company’s business model

  • UK unveils plans for bigger medicines price squeeze UK unveils plans for bigger medicines price squeeze

    However the government’s consultation document makes it clear that it sees little merit in maintaining the ‘business as usual’model, and stressed the need to control NHS expenditure.

  • Inside the patient-centricity bubble Inside the patient-centricity bubble

    The hybrid model. However, ringing true to pharma, innovation comes at a price. ... If you want to change your business model then it’s time to  focus on the people.

More from news
Approximately 1 fully matching, plus 236 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward. " /. ... Pharma has recognised the need to change its traditional business model and explore more collaborative ways of working.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    This will ultimately require an authentic customer-centred approach and the widespread redefinition of the old pharma business model. ... Companies, says Cath, should focus on how they can change their business model to become better, rather than

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    In April this year, a Goldman Sachs biotech report suggested that curing patients, as many gene therapies promise to, is not a good business model. ... Cell and gene therapies undoubtedly do pose difficult questions – but there is also no question of

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    This business model not only enables precise, secure and compliant engagement of staff within their workplace, it also delivers a revenue share back to the NHS trusts.

  • Deal Watch January 2018

    Spin-outs don't always last long as independent companies. In our recent annual deal review for 2017 we highlighted how the spin-out business model is alive and kicking and

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Moderna Therapeutics appoints chief business officer. Saqib Islam brings experience from Alexion Pharmaceuticals. ... Islam said: “ Already a clinical stage company, Moderna has extraordinary opportunities ahead of it, with its breakthrough science,

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics